These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30970161)

  • 1. Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe.
    Cave A; Kurz X; Arlett P
    Clin Pharmacol Ther; 2019 Jul; 106(1):36-39. PubMed ID: 30970161
    [No Abstract]   [Full Text] [Related]  

  • 2. The US Food and Drug Administration's Real-World Evidence Framework: A Commitment for Engagement and Transparency on Real-World Evidence.
    ElZarrad MK; Corrigan-Curay J
    Clin Pharmacol Ther; 2019 Jul; 106(1):33-35. PubMed ID: 30883700
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the Use of Real-World Evidence for Medical Devices: An Update From the National Evaluation System for Health Technology.
    Fleurence RL; Shuren J
    Clin Pharmacol Ther; 2019 Jul; 106(1):30-33. PubMed ID: 30888048
    [No Abstract]   [Full Text] [Related]  

  • 4. Information Patients Can Provide Will Strengthen the Real-World Evidence That Matters to Them.
    Nowell WB
    Clin Pharmacol Ther; 2019 Jul; 106(1):49-51. PubMed ID: 31112287
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-World Evidence of Treatment Effects: The Useful and the Misleading.
    Schneeweiss S
    Clin Pharmacol Ther; 2019 Jul; 106(1):43-44. PubMed ID: 30942896
    [No Abstract]   [Full Text] [Related]  

  • 6. Decentralized Trials in the Age of Real-World Evidence and Inclusivity in Clinical Investigations.
    Khozin S; Coravos A
    Clin Pharmacol Ther; 2019 Jul; 106(1):25-27. PubMed ID: 31013350
    [No Abstract]   [Full Text] [Related]  

  • 7. Barriers and Opportunities for Use of Patient Registries in Medicines Regulation.
    Olmo CA; McGettigan P; Kurz X
    Clin Pharmacol Ther; 2019 Jul; 106(1):39-42. PubMed ID: 30970160
    [No Abstract]   [Full Text] [Related]  

  • 8. Real-World Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety Surveillance.
    Dal Pan GJ
    Clin Pharmacol Ther; 2019 Jul; 106(1):28-30. PubMed ID: 30958565
    [No Abstract]   [Full Text] [Related]  

  • 9. EU agrees tighter standards for medical devices.
    Watson R
    BMJ; 2016 Jun; 353():i3058. PubMed ID: 27251309
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges in collecting, accessing and evaluating post market surveillance AERS in patients receiving dietary supplements.
    Kingston R
    Thromb Res; 2005; 117(1-2):137-44; discussion 145-51. PubMed ID: 16139875
    [No Abstract]   [Full Text] [Related]  

  • 11. Health care technology assessment in The Netherlands.
    Gelijns AC; Rigter H
    Int J Technol Assess Health Care; 1990; 6(1):157-63. PubMed ID: 2361817
    [No Abstract]   [Full Text] [Related]  

  • 12. From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer Patients.
    Lee JSH; Darcy KM; Hu H; Casablanca Y; Conrads TP; Dalgard CL; Freymann JB; Hanlon SE; Huang GD; Kvecher L; Maxwell GL; Meng F; Moncur JT; Turner C; Wells JM; Wilkerson MD; Zhu K; Ramoni RB; Shriver CD
    Clin Pharmacol Ther; 2019 Jul; 106(1):52-57. PubMed ID: 30838639
    [No Abstract]   [Full Text] [Related]  

  • 13. How to improve the quality of evidence when new treatments are funded conditional on collecting evidence of effectiveness and safety.
    Glynn D; Campbell B; Marlow M; Patrick H
    J Health Serv Res Policy; 2016 Apr; 21(2):71-2. PubMed ID: 26683884
    [No Abstract]   [Full Text] [Related]  

  • 14. Data Science Approaches for Effective Use of Mobile Device-Based Collection of Real-World Data.
    Omberg L; Chaibub Neto E; Mangravite LM
    Clin Pharmacol Ther; 2020 Apr; 107(4):719-721. PubMed ID: 32036612
    [No Abstract]   [Full Text] [Related]  

  • 15. Compliance in European pharmacovigilance: a regulatory view.
    Arlett PR; Harrison P
    Pharmacoepidemiol Drug Saf; 2001; 10(4):301-2. PubMed ID: 11760490
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical reflection on the collection and evaluation of adverse drug reaction data.
    Venulet J
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S48-53. PubMed ID: 3842691
    [No Abstract]   [Full Text] [Related]  

  • 17. Net clinical benefit: the art and science of jointly estimating benefits and risks of medical treatment.
    Towse A
    Value Health; 2010 Jun; 13 Suppl 1():S30-2. PubMed ID: 20618793
    [No Abstract]   [Full Text] [Related]  

  • 18. Statewide test of a new postmarketing drug surveillance system.
    Fisher S; Bryant SG; Solovitz BL; Kluge RM
    Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
    [No Abstract]   [Full Text] [Related]  

  • 19. Tagging medical devices.
    Med Device Technol; 2002 Nov; 13(9):76-7. PubMed ID: 12534163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of service life of sophisticated medical equipment].
    Toporkov AA
    Med Tekh; 2007; (3):26-33. PubMed ID: 17598479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.